[Guideline] Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, et al. Erectile Dysfunction. American Urological Association. Available at https://www.auanet.org/guidelines/male-sexual-dysfunction-erectile-dysfunction-(2018). 2018; Accessed: July 18, 2018.
Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res. 2002 Feb. 14 Suppl 1:S38-42. [Medline].
Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, et al. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012 Dec 25. 60(25):2618-27. [Medline].
Lopushnyan NA, Chitaley K. Genetics of erectile dysfunction. J Urol. 2012 Nov. 188(5):1676-83. [Medline].
Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol. 2003 Apr. 169(4):1437-42. [Medline].
Miner M, Seftel AD, Nehra A, Ganz P, Kloner RA, Montorsi P, et al. Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J. 2012 Jul. 164(1):21-8. [Medline].
Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug. 87(8):766-78. [Medline]. [Full Text].
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013:426-9.
Anatomy of the Lower Urinary Tract and Male Genitalia. Campbell-Walsh Urology 9th edition. Philadelphia: WB Saunders.;
Yucel S, Baskin LS. Identification of communicating branches among the dorsal, perineal and cavernous nerves of the penis. J Urol. 2003 Jul. 170(1):153-8. [Medline].
Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003 Aug. 170(2 Pt 2):S6-13; discussion S13-4. [Medline].
Chitaley K, Webb RC, Mills TM. RhoA/Rho-kinase: a novel player in the regulation of penile erection. Int J Impot Res. 2001 Apr. 13(2):67-72. [Medline].
Michel T, Feron O. Nitric oxide synthases: which, where, how, and why?. J Clin Invest. 1997 Nov 1. 100(9):2146-52. [Medline]. [Full Text].
Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. 1999 Feb. 83(3):269-73. [Medline].
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006 Jul. 60(7):762-9. [Medline]. [Full Text].
Guay AT. Testosterone and erectile physiology. Aging Male. 2006 Dec. 9(4):201-6. [Medline].
Zhang XH, Melman A, Disanto ME. Update on corpus cavernosum smooth muscle contractile pathways in erectile function: a role for testosterone?. J Sex Med. 2011 Jul. 8(7):1865-79. [Medline].
Foresta C, Caretta N, Rossato M, Garolla A, Ferlin A. Role of androgens in erectile function. J Urol. 2004 Jun. 171(6 Pt 1):2358-62, quiz 2435. [Medline].
Spitzer M, Basaria S, Travison TG, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med. 2012 Nov 20. 157(10):681-91. [Medline].
Alhathal N, Elshal AM, Carrier S. Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review. Can Urol Assoc J. 2012 Aug. 6(4):269-74. [Medline]. [Full Text].
Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology. 1999 Apr. 140(4):1861-8. [Medline].
Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, et al. Effects of medical or surgical castration on erectile function in an animal model. J Androl. 2003 May-Jun. 24(3):381-7. [Medline].
Lugg JA, Rajfer J, González-Cadavid NF. Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology. 1995 Apr. 136(4):1495-501. [Medline].
Reilly CM, Lewis RW, Stopper VS, Mills TM. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway. J Androl. 1997 Nov-Dec. 18(6):588-94. [Medline].
Costabile RA. Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol. 2003 Aug. 170(2 Pt 2):S35-8; discussion S39. [Medline].
De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, et al. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol. 2003 Apr. 169(4):1422-8. [Medline].
Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000 Mar. 163(3):788-91. [Medline].
Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol. 2000 Oct. 164(4):1188-91. [Medline].
Larson TR. Current treatment options for benign prostatic hyperplasia and their impact on sexual function. Urology. 2003 Apr. 61(4):692-8. [Medline].
Chen CM, Tsai MJ, Wei PJ, Su YC, Yang CJ, et al. Erectile Dysfunction in Patients with Sleep Apnea--A Nationwide Population-Based Study. PLoS One. 2015. 10 (7):e0132510. [Medline].
Shen TC, Chen WC, Lin CL, Chen CH, Tu CY, et al. The risk of erectile dysfunction in chronic obstructive pulmonary disease: a population-based cohort study in Taiwan. Medicine (Baltimore). 2015 Apr. 94 (14):e448. [Medline].
Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med. 1998 Jul-Aug. 60(4):458-65. [Medline].
Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol. 2000 Jul 20. 86(2A):41F-45F. [Medline].
Kawanishi Y, Lee KS, Kimura K, Koizumi T, Nakatsuji H, Kojima K, et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res. 2001 Apr. 13(2):100-3. [Medline].
Kloner RA, Mullin SH, Shook T, Matthews R, Mayeda G, Burstein S, et al. Erectile dysfunction in the cardiac patient: how common and should we treat?. J Urol. 2003 Aug. 170(2 Pt 2):S46-50; discussion S50. [Medline].
Valicenti RK, Bissonette EA, Chen C, Theodorescu D. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol. 2002 Dec. 168(6):2499-504; discussion 2504. [Medline].
Marceau L, Kleinman K, Goldstein I, McKinlay J. Does bicycling contribute to the risk of erectile dysfunction? Results from the Massachusetts Male Aging Study (MMAS). Int J Impot Res. 2001 Oct. 13(5):298-302. [Medline].
Goldstein I, Lurie AL, Lubisich JP. Bicycle riding, perineal trauma, and erectile dysfunction: data and solutions. Curr Urol Rep. 2007 Nov. 8(6):491-7. [Medline].
Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017 Sep. 34 (9):1185-1192. [Medline].
Seftel AD, Strohl KP, Loye TL, Bayard D, Kress J, Netzer NC. Erectile dysfunction and symptoms of sleep disorders. Sleep. 2002 Sep 15. 25(6):643-7. [Medline].
Heruti R, Shochat T, Tekes-Manova D, Ashkenazi I, Justo D. Association between erectile dysfunction and sleep disorders measured by self-assessment questionnaires in adult men. J Sex Med. 2005 Jul. 2(4):543-50. [Medline].
Cosgrove DJ, Gordon Z, Bernie JE, Hami S, Montoya D, Stein MB, et al. Sexual dysfunction in combat veterans with post-traumatic stress disorder. Urology. 2002 Nov. 60(5):881-4. [Medline].
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999 Dec. 11(6):319-26. [Medline].
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun. 49(6):822-30. [Medline].
Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21. 306(11):1205-14. [Medline].
Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol. 2003 Oct. 170(4 Pt 1):1278-83. [Medline].
Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK, et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology. 2003 Jul. 62(1):110-5. [Medline].
Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. BMJ. 2016. 354:i4823. [Full Text].
Glina S, Sharlip ID, Hellstrom WJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013 Jan. 10(1):115-9. [Medline].
Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 1995 Nov. 22(4):699-709. [Medline].
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999 Feb 10. 281(6):537-44. [Medline].
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000 Dec. 12(6):305-11. [Medline].
Niederberger C, Lonsdale J. Erectile dysfunction - patient characteristics and attitudes based on a large-scale male health study conducted in US, Europe, Mexico and Brazil. [abstract 594]. J Urol. 2002. 167:
Araujo AB, Travison TG, Ganz P, Chiu GR, Kupelian V, Rosen RC, et al. Erectile dysfunction and mortality. J Sex Med. 2009 Sep. 6(9):2445-54. [Medline].
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005 Dec 21. 294(23):2996-3002. [Medline].
O’Riordan M. Erectile Dysfunction Linked With Increased Risk of CV Events. Available at http://www.medscape.com/viewarticle/777474. Accessed: March 19, 2013.
Chou PS, Chou WP, Chen MC, Lai CL, Wen YC, et al. Newly diagnosed erectile dysfunction and risk of depression: a population-based 5-year follow-up study in Taiwan. J Sex Med. 2015 Mar. 12 (3):804-12. [Medline].
Large waistline linked to urinary and erectile difficulties. Harv Mens Health Watch. 2012 Oct. 17(3):8. [Medline].
Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006 Jan. 3(1):28-36; discussion 36. [Medline].
Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005 Dec 26. 96(12B):19M-23M. [Medline].
Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009 Feb. 84(2):108-13. [Medline]. [Full Text].
Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract. 2002 Feb. 19(1):95-8. [Medline].
Wessells H, Roy J, Bannow J, Grayhack J, Matsumoto AM, Tenover L, et al. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology. 2003 Mar. 61(3):579-84. [Medline].
Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol. 2008 Apr. 23 (3):201-9. [Medline].
Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999 Apr. 53(4):793-9. [Medline].
Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res. 2000 Aug. 12(4):197-204. [Medline].
Rosen RC, Fisher WA, Beneke M, Homering M, Evers T. The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. BJU Int. 2007 Apr. 99(4):849-59. [Medline].
Swindle RW, Cameron AE, Lockhart DC, Rosen RC. The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav. 2004 Feb. 33(1):19-30. [Medline].
Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res. 2004 Feb. 16(1):30-8. [Medline].
[Guideline] The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel. Int J Impot Res. 1999 Apr. 11(2):59-70; discussion 70-4. [Medline].
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004 Jul. 1(1):6-23. [Medline].
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014 May. 101 (5):1271-9. [Medline].
Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev. 2012 Nov 14. 11:CD003546. [Medline].
Fujioi J, Iwamoto K, Banno M, Kikuchi T, Aleksic B, Ozaki N. Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study. Pharmacopsychiatry. 2016 Sep 22. [Medline].
Teoh JB, Yee A, Danaee M, Ng CG, Sulaiman AH. Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life. J Addict Med. 2017 Jan/Feb. 11 (1):40-46. [Medline].
Yee A, Loh HS, Ong TA, Ng CG, Sulaiman AH. Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. Am J Mens Health. 2018 Jul 1. 1557988318784152. [Medline].
[Guideline] Rosen RC, Jackson G, Kostis JB. Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference. Curr Urol Rep. 2006 Nov. 7(6):490-6. [Medline].
Gupta BP, Murad MH, Clifton MM, et al. The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction: A Systematic Review and Meta-analysis. Arch Intern Med. 2011 Sep 12. [Medline].
Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol. 1999 Jan. 33(1):273-82. [Medline].
Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT. Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med. 2004 Sep. 1(2):161-7. [Medline].
Wang TD, Lee WJ, Yang SC, Lin PC, Tai HC, Liu SP, et al. Clinical and Imaging Outcomes up to 1 Year Following Balloon Angioplasty for Isolated Penile Artery Stenoses in Patients With Erectile Dysfunction: The PERFECT-2 Study. J Endovasc Ther. 2016 Sep 14. [Medline].
Angulo JC, Arance I, de Las Heras MM, Meilán E, Esquinas C, Andrés EM. Efficacy of low-intensity shock wave therapy for erectile dysfunction: A systematic review and meta-analysis. Actas Urol Esp. 2016 Aug 9. [Medline].
Stein J. Penile Shock Wave Therapy Helps Men With Severe Erectile Dysfunction. Medscape Medical News. Available at http://www.medscape.com/viewarticle/739414#vp_2. March 22, 2011; Accessed: September 25, 2016.
Peak TC, Yafi FA, Sangkum P, Hellstrom WJ. Emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2015 Jun. 20 (2):263-75. [Medline].
Montorsi F, Salonia A, Deho' F, Cestari A, Guazzoni G, Rigatti P, et al. Pharmacological management of erectile dysfunction. BJU Int. 2003 Mar. 91(5):446-54. [Medline].
Goldstein I, Jones LA, Belkoff LH, Karlin GS, Bowden CH, Peterson CA, et al. Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus. Mayo Clin Proc. 2012 Jul 31. [Medline].
[Guideline] Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010 May. 57 (5):804-14. [Medline]. [Full Text].
Gutierrez P, Hernandez P, Mas M. Combining programmed intracavernous PGE1 injections and sildenafil on demand to salvage sildenafil nonresponders. Int J Impot Res. 2005 Jul-Aug. 17(4):354-8. [Medline].
Aversa A, Isidori AM, De Martino MU, Caprio M, Fabbrini E, Rocchietti-March M, et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf). 2000 Oct. 53(4):517-22. [Medline].
Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003 May. 58(5):632-8. [Medline].
Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab. 1995 Dec. 80(12):3546-52. [Medline].
Jain P, Rademaker AW, McVary KT. Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol. 2000 Aug. 164(2):371-5. [Medline].
Morales A, Johnston B, Heaton JW, Clark A. Oral androgens in the treatment of hypogonadal impotent men. J Urol. 1994 Oct. 152(4):1115-8. [Medline].
Shabsigh R, Kaufman JM, Steidle C. Testosterone replacement therapy with testosterone-gel 1% converts sildenafil nonresponders to responders in men with hypogonadism and erectile dysfunction who failed prior sildenafil therapy. [abstract 954]. J Urol. 2003. S169S.
Corona G, Isidori AM, Buvat J, Aversa A, Rastrelli G, Hackett G, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014 Jun. 11 (6):1577-92. [Medline].
Aversa A, Francomano D, Lenzi A. Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?. Expert Opin Pharmacother. 2015 Apr. 16 (5):625-8. [Medline].
Hedlund H, Hedlund P. Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models. Scand J Urol Nephrol Suppl. 1996. 179:129-38. [Medline].
Lin CS, Ho HC, Chen KC, Lin G, Nunes L, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int. 2002 Jun. 89(9):955-60. [Medline].
Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996 Apr 4. 334(14):873-7. [Medline].
Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology. 2000 Apr. 55(4):477-80. [Medline].
The European Alprostadil Study Group. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group. Br J Urol. 1998 Oct. 82(4):538-43. [Medline].
Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama à Nijeholt GA, et al. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group. Br J Urol. 1998 Jun. 81(6):889-94. [Medline].
Goldstein I, Payton TR, Schechter PJ. A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. Urology. 2001 Feb. 57(2):301-5. [Medline].
Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res. 2003 Feb. 15(1):26-37. [Medline].
Burchardt M, Burchardt T, Anastasiadis AG, Buttyan R, de la Taille A, Shabsigh A, et al. Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis. Urology. 2005 Sep. 66(3):665-70. [Medline].
Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998 Feb. 159(2):433-6. [Medline].
Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol. 1997. 15(1):78-82. [Medline].
Lewis RW. Long-term results of penile prosthetic implants. Urol Clin North Am. 1995 Nov. 22(4):847-56. [Medline].
Mulhall JP, Ahmed A, Branch J, Parker M. Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery. J Urol. 2003 Apr. 169(4):1429-33. [Medline].
Canguven O, Talib RA, Campbell J, De Young L, El Ansari W, Al-Ansari A. Is the daily use of vacuum erection device for a month before penile prosthesis implantation beneficial? a randomized controlled trial. Andrology. 2016 Sep 21. [Medline].
Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol. 2003 Jul. 170(1):159-63. [Medline].
Kalaitzidou I, Venetikou MS, Konstadinidis K, Artemiadis AK, Chrousos G, Darviri C. Stress management and erectile dysfunction: a pilot comparative study. Andrologia. 2013 Jul 3. [Medline].
Maiorino MI, Bellastella G, Caputo M, Castaldo F, Improta MR, Giugliano D, et al. Effects of Mediterranean diet on sexual function in people with newly diagnosed type 2 diabetes: The MÈDITA trial. J Diabetes Complications. 2016 Aug 12. [Medline].
Silva AB, Sousa N, Azevedo LF, Martins C. Physical activity and exercise for erectile dysfunction: systematic review and meta-analysis. Br J Sports Med. 2017 Oct. 51 (19):1419-1424. [Medline].
Hewitt PE, Wagstaff W. ABC of transfusion. The blood donor and tests on donor blood. BMJ. 1989 Dec 2. 299(6712):1391-4. [Medline]. [Full Text].
Anderson P. Opioid use linked to erectile dysfunction. Medscape Medical News. May 17, 2013. [Full Text].
Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, et al. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Phila Pa 1976). 2013 May 15. 38(11):909-15. [Medline]. [Full Text].
The presence of normal skin sensation adequate to produce an erection is measured with this device.
